Advanced Search

    Technical Analysis for SOLTF - Sosei Co. Ltd

    Grade Last Price % Change Price Change
    A 22.0800 -1.41% -0.3150
    SOLTF closed down 1.41 percent on Friday, June 2, 2023, on 15 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong N/A N/A Up
    Historical SOLTF trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Overbought Stochastic Strength 0.00%
    Gapped Down Weakness 0.00%
    Pocket Pivot Bullish Swing Setup -1.41%
    Narrow Range Bar Range Contraction -1.41%
    Stochastic Reached Overbought Strength -1.41%
    Gapped Up Strength -1.41%
    Overbought Stochastic Strength -1.41%
    Slingshot Bullish Bullish Swing Setup -0.38%
    Narrow Range Bar Range Contraction -0.38%
    Older End-of-Day Signals for SOLTF ...

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SOLTF Chart by TradingView
    Basic chart:

    Profile

    Sosei Co. Ltd Description

    Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.

    Classification
    Keywords: Health Biopharmaceutical Life Sciences Pharmaceutical Industry Neurological Disorders Asthma Chronic Obstructive Pulmonary Disease Obesity Astrazeneca Inflammatory Bowel Disease Pfizer Diabetes Mellitus Biopharmaceutical Products Genentech Neurological Diseases Abbvie Inc.

    Is SOLTF a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.782
    52 Week Low 15.9
    Average Volume 2,050
    200-Day Moving Average 0.0000
    50-Day Moving Average 0.0000
    20-Day Moving Average 20.6579
    10-Day Moving Average 21.3490
    Average True Range 0.5579
    RSI (14) 62.26
    ADX 29.04
    +DI 60.5395
    -DI 33.7238
    Chandelier Exit (Long, 3 ATRs) 21.1083
    Chandelier Exit (Short, 3 ATRs) 19.3386
    Upper Bollinger Bands 22.6732
    Lower Bollinger Band 18.6426
    Percent B (%b) 0.85
    BandWidth 19.5112
    MACD Line 1.0093
    MACD Signal Line 0.8799
    MACD Histogram 0.1294
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 22.0800
    Resistance 3 (R3) 22.0800 22.0800 22.0800
    Resistance 2 (R2) 22.0800 22.0800 22.0800 22.0800
    Resistance 1 (R1) 22.0800 22.0800 22.0800 22.0800 22.0800
    Pivot Point 22.0800 22.0800 22.0800 22.0800 22.0800
    Support 1 (S1) 22.0800 22.0800 22.0800 22.0800 22.0800
    Support 2 (S2) 22.0800 22.0800 22.0800 22.0800
    Support 3 (S3) 22.0800 22.0800 22.0800
    Support 4 (S4) 22.0800